Anika Therapeutics, Inc. — Director's Dealing 2021

May 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2021-05-12

Reporting Person: LAND RAYMOND J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-12	Common Stock	S	2000	$42.60	Disposed	7953	Direct

Footnotes

F1: On May 12, 2021, Mr. Land sold 2,000 shares in multiple trades ranging from $42.50 to $42.72. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.